Aggrenox (aspirin/extended release dipyridamole) Capsules
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
November 2015
WARNINGS AND PRECAUTIONS
Risk of Bleeding
Risk factors for bleeding include the use of other drugs that increase...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts